Search research articles
Contact Us
Filters
Showing results (271-280 of 336) with videos related to
Page
of 34
Sort By:
JAMA Oncology
|
December 16, 2017
Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical Trial
Debra L Richardson, Michael W Sill, Robert L Coleman, et al.
International Journal of Cancer
|
May 18, 2010
Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium
Galina Lurie, Lynne R Wilkens, Pamela J Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2020
Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209)
David S Miller, Virginia L Filiaci, Robert S Mannel, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 14, 2013
Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls
Kathryn L Terry, Stalo Karageorgi, Yurii B Shvetsov, et al.
Nature Medicine
|
August 15, 2017
Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors
Hana Janouskova, Geniver El Tekle, Elisa Bellini, et al.
Cancer Science
|
December 17, 2017
Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium
Tomotaka Ugai, Linda E Kelemen, Mika Mizuno, et al.
BMC Cancer
|
January 24, 2013
Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium
Linda E Kelemen, Elisa V Bandera, Kathryn L Terry, et al.
Epidemiology (Cambridge, Mass.)
|
February 7, 2020
Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer: A Complicated Relationship Explored
Alice W Lee, Anna H Wu, Ashley Wiensch, et al.
Plos One
|
February 25, 2011
The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women
Galina Lurie, Mia M Gaudet, Amanda B Spurdle, et al.
Journal of the National Cancer Institute
|
July 12, 2023
A framework for assessing interactions for risk stratification models: the example of ovarian cancer
Minh Tung Phung, Alice W Lee, Karen McLean, et al.
Page
of 34
Search research articles
Search
Showing results (271-280 of 336) with videos related to
Sort By:
Page
of 34
JAMA Oncology
|
December 16, 2017
Paclitaxel With and Without Pazopanib for Persistent or Recurrent Ovarian Cancer: A Randomized Clinical Trial
Debra L Richardson, Michael W Sill, Robert L Coleman, et al.
International Journal of Cancer
|
May 18, 2010
Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium
Galina Lurie, Lynne R Wilkens, Pamela J Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 20, 2020
Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209)
David S Miller, Virginia L Filiaci, Robert S Mannel, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
June 14, 2013
Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls
Kathryn L Terry, Stalo Karageorgi, Yurii B Shvetsov, et al.
Nature Medicine
|
August 15, 2017
Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors
Hana Janouskova, Geniver El Tekle, Elisa Bellini, et al.
Cancer Science
|
December 17, 2017
Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium
Tomotaka Ugai, Linda E Kelemen, Mika Mizuno, et al.
BMC Cancer
|
January 24, 2013
Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association Consortium
Linda E Kelemen, Elisa V Bandera, Kathryn L Terry, et al.
Epidemiology (Cambridge, Mass.)
|
February 7, 2020
Estrogen Plus Progestin Hormone Therapy and Ovarian Cancer: A Complicated Relationship Explored
Alice W Lee, Anna H Wu, Ashley Wiensch, et al.
Plos One
|
February 25, 2011
The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women
Galina Lurie, Mia M Gaudet, Amanda B Spurdle, et al.
Journal of the National Cancer Institute
|
July 12, 2023
A framework for assessing interactions for risk stratification models: the example of ovarian cancer
Minh Tung Phung, Alice W Lee, Karen McLean, et al.
Page
of 34